Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1973 Apr;47(4):711–718. doi: 10.1111/j.1476-5381.1973.tb08198.x

Role of pre- and postjunctional inhibition by prostaglandin E2 of lipolysis induced by sympathetic nerve stimulation in dog subcutaneous adipose tissue in situ

B B Fredholm, P Hedqvist
PMCID: PMC1776075  PMID: 4723796

Abstract

1. Canine subcutaneous adipose tissue was isolated and autoperfused in situ after labelling of the noradrenaline stores by 3H-(—)noradrenaline.

2. Prostaglandin E2 (10-200 ng/ml) increased blood flow and glucose uptake, and caused a dose-dependent inhibition of lipolysis induced by sympathetic nerve stimulation (4 Hz). The actions of exogenous prostaglandin E2 are therefore similar to those of prostaglandin E1 in this tissue. There were no consistent effects of prostaglandin E2 on the vasoconstriction or on the 3H-noradrenaline overflow induced by nerve stimulation.

3. Phenoxybenzamine (1·5-2 mg i.a.) caused a 5-fold increase in 3H-noradrenaline overflow and a 95% reduction of the vasoconstrictor response to nerve stimulation. The lipolytic response was similar to that of the control. Prostaglandin E2 (100-200 ng/ml) administered after phenoxybenzamine caused a 90% inhibition of lipolysis, while the vasoconstrictor response was enhanced to about 50% of control. Prostaglandin E2 inhibited 3H-noradrenaline overflow by about 50% but it was still larger than that of the control.

4. It is suggested that exogenous prostaglandin E2 inhibits lipolysis induced by sympathetic nerve stimulation mainly by a postjunctional action in canine subcutaneous adipose tissue.

Full text

PDF
711

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergström S., Carlson L. A., Weeks J. R. The prostaglandins: a family of biologically active lipids. Pharmacol Rev. 1968 Mar;20(1):1–48. [PubMed] [Google Scholar]
  2. Folkow B., Häggendal J., Lisander B. Extent of release and elimination of noradrenaline at peripheral adrenergic nerve terminals. Acta Physiol Scand Suppl. 1967;307:1–38. [PubMed] [Google Scholar]
  3. Fredholm B. B., Rosell S. Effects of prostaglandin E1 in canine subcutaneous adipose tissue in situ. Acta Physiol Scand. 1970 Dec;80(4):450–458. doi: 10.1111/j.1748-1716.1970.tb04813.x. [DOI] [PubMed] [Google Scholar]
  4. Fredholm B. B., Rosell S. Fate of 3H-noradrenaline in canine subcutaneous adipose tissue. Acta Physiol Scand. 1970 Nov;80(3):404–411. doi: 10.1111/j.1748-1716.1970.tb04804.x. [DOI] [PubMed] [Google Scholar]
  5. Fredholm B. B., Rosell S., Strandberg K. Release of prostaglandin-like material from canine subcutaneous adipose tissue by nerve stimulation. Acta Physiol Scand. 1970 Jun;79(2):18A–19A. [PubMed] [Google Scholar]
  6. Fredholm B., Rosell S. Effects of adrenergic blocking agents on lipid mobilization from canine subcutaneous adipose tissue after sympathetic nerve stimulation. J Pharmacol Exp Ther. 1968 Jan;159(1):1–7. [PubMed] [Google Scholar]
  7. Hedqvist P. Studies on the effect of prostaglandins E1 and E2 on the sympathetic neuromuscular transmission in some animal tissues. Acta Physiol Scand Suppl. 1970;345:1–40. [PubMed] [Google Scholar]
  8. Illiano G., Cuatrecasas P. Endogenous prostaglandins modulate lipolytic processes in adipose tissue. Nat New Biol. 1971 Nov 17;234(46):72–74. doi: 10.1038/newbio234072a0. [DOI] [PubMed] [Google Scholar]
  9. LEVIN K., LINDE S. [Determination of glucose in blood, cerebrospinal fluid and urine with a new glucose oxidase reagent]. Sven Lakartidn. 1962 Oct 18;59:3016–3026. [PubMed] [Google Scholar]
  10. Laurell S., Tibbling G. An enzymatic fluorometric micromethod for the determination of glycerol. Clin Chim Acta. 1966 Mar;13(3):317–322. doi: 10.1016/0009-8981(66)90210-5. [DOI] [PubMed] [Google Scholar]
  11. ROSELL S., KOPIN I. J., AXELROD J. FATE OF H3-NORADRENALINE IN SKELETAL MUSCLE BEFORE AND FOLLOWING SYMPATHETIC STIMULATION. Am J Physiol. 1963 Aug;205:317–321. doi: 10.1152/ajplegacy.1963.205.2.317. [DOI] [PubMed] [Google Scholar]
  12. Rosell S. Release of free fatty acids from subcutaneous adipose tissue in dogs following sympathetic nerve stimulation. Acta Physiol Scand. 1966 Jul-Aug;67(3):343–351. doi: 10.1111/j.1748-1716.1966.tb03320.x. [DOI] [PubMed] [Google Scholar]
  13. STEINBERG D., VAUGHAN M., NESTEL P. J., BERGSTROM S. Effects of prostaglandin E opposing those of catecholamines on blood pressure and on triglyceride breakdown in adipose tissue. Biochem Pharmacol. 1963 Jul;12:764–766. doi: 10.1016/0006-2952(63)90053-4. [DOI] [PubMed] [Google Scholar]
  14. Shaw J. E., Ramwell P. W. Release of prostaglandin from rat epididymal fat pad on nervous and hormonal stimulation. J Biol Chem. 1968 Apr 10;243(7):1498–1503. [PubMed] [Google Scholar]
  15. Stjärne L., Lishajko F. Drug-induced inhibition of noradrenaline synthesis in vitro in bovine splenic nerve tissue. Br J Pharmacol Chemother. 1966 Aug;27(2):398–404. doi: 10.1111/j.1476-5381.1966.tb01671.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. von EULER U., LISHAJKO F. Improved technique for the fluorimetric estimation of catecholamines. Acta Physiol Scand. 1961 Apr;51:348–355. doi: 10.1111/j.1748-1716.1961.tb02128.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES